BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,684,563 | -10.2% | 632,710 | -41.4% | 0.04% | -5.3% |
| Q2 2023 | $18,580,455 | +3.7% | 1,080,259 | 0.0% | 0.04% | -2.6% |
| Q1 2023 | $17,910,694 | +185.3% | 1,080,259 | +31.1% | 0.04% | +178.6% |
| Q4 2022 | $6,278,567 | +12.5% | 823,959 | +46.7% | 0.01% | 0.0% |
| Q3 2022 | $5,581,000 | +25.5% | 561,498 | +14.7% | 0.01% | +27.3% |
| Q2 2022 | $4,446,000 | -5.8% | 489,712 | +5.3% | 0.01% | +10.0% |
| Q1 2022 | $4,720,000 | -40.1% | 465,083 | -1.5% | 0.01% | -33.3% |
| Q4 2021 | $7,877,000 | -64.6% | 472,269 | -0.5% | 0.02% | -67.4% |
| Q3 2021 | $22,255,000 | -5.0% | 474,820 | +23.6% | 0.05% | -2.1% |
| Q2 2021 | $23,418,000 | +7.0% | 384,138 | +8.1% | 0.05% | 0.0% |
| Q1 2021 | $21,888,000 | +71.3% | 355,323 | +97.7% | 0.05% | +62.1% |
| Q4 2020 | $12,778,000 | +64.8% | 179,706 | -13.0% | 0.03% | +45.0% |
| Q3 2020 | $7,753,000 | +59.5% | 206,651 | +38.6% | 0.02% | +53.8% |
| Q2 2020 | $4,862,000 | +17.8% | 149,083 | +4.8% | 0.01% | -7.1% |
| Q1 2020 | $4,126,000 | +6.6% | 142,235 | +28.8% | 0.01% | +40.0% |
| Q4 2019 | $3,870,000 | – | 110,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |